Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-12
DOI
10.1038/s41598-018-36335-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between levels of synovial anti-citrullinated peptide antibodies and neutrophil response in patients with rheumatoid arthritis
- (2018) Carolina V. Gorlino et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus
- (2018) Catalina Burbano et al. Frontiers in Immunology
- Autoantibodies in inflammatory arthritis
- (2016) P. Conigliaro et al. AUTOIMMUNITY REVIEWS
- First in vivo detection and characterization of hyaluronan-coated extracellular vesicles in human synovial fluid
- (2016) Anne-Mari Mustonen et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Extracellular vesicles — new tool for joint repair and regeneration
- (2016) Jos Malda et al. Nature Reviews Rheumatology
- Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis
- (2016) Anca I. Catrina et al. Nature Reviews Rheumatology
- Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
- (2016) Arthur Kavanaugh Therapeutics and Clinical Risk Management
- Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism
- (2015) Gustaf Wigerblad et al. ANNALS OF THE RHEUMATIC DISEASES
- Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss
- (2015) Akilan Krishnamurthy et al. ANNALS OF THE RHEUMATIC DISEASES
- Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation
- (2015) R. Scrivo et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune Responses
- (2015) Catalina Burbano et al. MEDIATORS OF INFLAMMATION
- Modulatory Effects of CD14+CD16++ Monocytes on CD14++CD16− Monocytes: A Possible Explanation of Monocyte Alterations in Systemic Lupus Erythematosus
- (2014) C. Burbano et al. Arthritis & Rheumatology
- Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
- (2013) M Neovius et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeting Interleukin-6 in Rheumatoid Arthritis
- (2013) Md Yuzaiful Md Yusof et al. DRUGS
- Macrophage biology in development, homeostasis and disease
- (2013) Thomas A. Wynn et al. NATURE
- Automatic Classification of Cellular Expression by Nonlinear Stochastic Embedding (ACCENSE)
- (2013) K. Shekhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
- (2013) José A Gómez-Puerta et al. ARTHRITIS RESEARCH & THERAPY
- Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation
- (2012) Christoffer T. Nielsen et al. ARTHRITIS AND RHEUMATISM
- The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes
- (2012) Nathalie Cloutier et al. EMBO Molecular Medicine
- Improved Flow Cytometric Assessment Reveals Distinct Microvesicle (Cell-Derived Microparticle) Signatures in Joint Diseases
- (2012) Bence György et al. PLoS One
- Targeting monocytes/macrophages in the treatment of rheumatoid arthritis
- (2012) J.-L. Davignon et al. RHEUMATOLOGY
- The CD14bright CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population
- (2011) Manuela Rossol et al. ARTHRITIS AND RHEUMATISM
- Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
- (2011) Morgane Baron et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Soluble CD14 and CD14 Polymorphisms in Rheumatoid Arthritis
- (2011) TED R. MIKULS et al. JOURNAL OF RHEUMATOLOGY
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis
- (2011) Isidoro González-Álvaro et al. PLoS One
- Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infection
- (2011) Diana Castaño et al. TUBERCULOSIS
- The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis
- (2010) D. van der Woude et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) D. Aletaha et al. ANNALS OF THE RHEUMATIC DISEASES
- Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid Arthritis
- (2010) R. MU et al. JOURNAL OF RHEUMATOLOGY
- Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis
- (2010) K. Ohmura et al. RHEUMATOLOGY
- Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
- (2010) E. Boilard et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started